A prospective study on the use of ultralow-dose computed tomography with iterative reconstruction for the follow-up of patients liver and renal abscess by 구남수 et al.
RESEARCH ARTICLE
A prospective study on the use of ultralow-
dose computed tomography with iterative
reconstruction for the follow-up of patients
liver and renal abscess
Nieun Seo1, Mi-Suk Park1, Jun Yong ChoiID
2,3, Joon-Sup YeomID
2,3, Myeong-Jin Kim1,
Yong Eun ChungID
1☯*, Nam Su Ku2,3☯*
1 Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea, 2 Department
of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, 3 AIDS Research
Institute, Yonsei University College of Medicine, Seoul, Republic of Korea
☯ These authors contributed equally to this work.
* smileboy9@yuhs.ac (NSK); yelv@yuhs.ac (YEC)
Abstract
Background
Radiation dose reduction is a major concern in patients who undergo computed tomography
(CT) to follow liver and renal abscess.
Objectives
The purpose of this study is to investigate the feasibility of ultralow-dose CT with iterative
reconstruction (IR) to follow patients with liver and renal abscess.
Methods
This prospective study included 18 patients who underwent ultralow-dose CT with IR to follow
abscesses (liver abscesses in 10 patients and renal abscesses in 8 patients; ULD group).
The control group consisted of 14 patients who underwent follow-up standard-dose CT for
liver abscesses during the same period. The objective image noise was evaluated by measur-
ing standard deviation (SD) in the liver and subcutaneous fat to select a specific IR for qualita-
tive analysis. Two radiologists independently evaluated subjective image quality, noise, and
diagnostic confidence to evaluate abscess using a five-point Likert scale. Qualitative parame-
ters were compared between the ULD and control groups with the Mann-Whitney U test.
Results
The mean CT dose index volume and dose length product of standard-dose CT were 8.7 ±
1.8 mGy and 555.8 ± 142.8 mGy�cm, respectively. Mean dose reduction of ultralow-dose
CT was 71.8% compared to standard-dose CT. After measuring SDs, iDose level 5, which
showed similar SD to standard-dose CT in both the subcutaneous fat and liver (P = 0.076,
and P = 0.124), was selected for qualitative analysis. Ultralow-dose CT showed slightly
worse subjective image quality (P < 0.001 for reader 1, and P = 0.005 for reader 2) and
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noise (P = 0.004 for reader 1, and P = 0.001 for reader 2) than standard-dose CT. However,
the diagnostic confidence of ultralow-dose CT for evaluating abscess was comparably
excellent to standard-dose CT (P = 0.808 for reader 1, and P = 0.301 for reader 2).
Conclusions
Ultralow-dose CT with IR can be used in the follow-up of liver and renal abscess with compa-
rable diagnostic confidence.
Introduction
Intra-abdominal abscesses can be clinically suspected in patients with acute abdominal pain
and fever. Appropriate diagnosis and management of intra-abdominal abscess is important,
because mortality rates can be as high as 80 to 100% when abscesses are left untreated [1–3].
Even after initial percutaneous drainage, abscess recurrence can occur to increase morbidity
and mortality rates [4–7]. Therefore, in those patients with intra-abdominal abscess, imaging
studies for initial diagnosis and follow-up are essential. Contrast-enhanced computed tomog-
raphy (CT) has been considered the best imaging modality for the accurate diagnosis of intra-
abdominal abscess [8, 9]. CT also plays an important role when deciding treatment options
and guiding the drainage procedure for abscess [10–12]. After appropriate treatment such as
antibiotics or drainage procedures, most patients undergo follow-up CT scans to evaluate
treatment response within a short time interval. According to a recently published study that
included patients with inflammatory bowel disease and intra-abdominal abscess, the mean
total number of follow-up CT performed during an abscess episode was 5.5 ± 3.7 in patients
with total radiation dose > 50 mSv, and 2.4 ± 1.4 in those with total radiation dose < 50 mSv.
The mean effective dose per follow-up CT was 5.96 ± 4.4 mSv [13]. Repeating CT scans to fol-
low intra-abdominal abscesses inevitably increases a patient’s radiation exposure.
When following intra-abdominal abscesses such as liver and renal abscesses, CT with radia-
tion doses lower than initial CT may be acceptable, because a diagnosis has already been estab-
lished with the initial standard-dose CT. According to the “as low as reasonably achievable”
principle, it is of utmost importance to reduce the radiation dose of CT while preserving diag-
nostic image quality [14]. Iterative reconstruction (IR) algorithms have widely been used to
reduce image noise while maintaining image quality, which has enabled significant dose
reduction of body CT [15–18].
Recently, a few studies have investigated the performance of ultralow-dose CT (with approxi-
mately 70–90% dose reduction compared to conventional CT) with various IR techniques in
the abdomen, to see its potential for CT colonography, evaluation of urolithiasis, detection and
characterization of focal liver lesions, or follow-up of patients with malignant lymphoma [19–
22]. Furthermore, reducing radiation exposure is particularly important for benign diseases
such as abdominal abscess for which we can expect normal life expectancy if a patient recovers
without complications. In this study, we aimed to investigate the feasibility of using ultralow-
dose abdominal CT with an IR algorithm to follow patients with liver and renal abscesses.
Materials and methods
Phantom study
We performed a phantom study using an anthropomorphic phantom (Model 701-G-ATOM
Adult Male Phantom, CIRS, Norfolk, Virginia, USA) to determine the optimal radiation dose
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for ultralow-dose CT. The phantom was imaged on a CT device (Brilliance iCT, Philips
Healthcare, Cleveland, OH) with the same parameters to be used in the clinical study other
than the dose right index (DRI). DRI was developed to preserve consistent image quality
regardless of estimated body weight. As routine clinical abdominopelvic CT scans are per-
formed using DRI 14–16 in our institution, we aimed for at least 50–70% reduction in radia-
tion dose compared to standard-dose CT when evaluating possible radiation doses for
ultralow-dose CT. The radiation doses for each scan of the phantom with different DRI are
presented in Table 1. Effective dose decreased 50.2% on the scan with DRI 9 compared with
the scan with DRI 15. Based on the results of this phantom study, we chose DRI 9 for ultralow-
dose CT in our clinical study.
Patients
This prospective study was approved by Institutional Review Board of Severance Hospital,
Yonsei University Health System (No. 4-2015-0413), and written informed consent was
obtained from all patients. From November 2015 to March 2019, patients who met the follow-
ing criteria were enrolled: (a) patients who had clinically suspected intra-abdominal abscess,
(b) patients who underwent initial standard-dose contrast-enhanced abdominopelvic CT in
the emergency room, (c) and patients who agreed to participate in this study. Three to 6 weeks
after the first CT scan, patients included in this study underwent ultralow-dose CT in a CT
room in the Cancer Center. Among 20 patients who satisfied the above criteria, two patients
were excluded whose raw CT data had been lost. Therefore, a total of 18 patients were included
in the ultralow-dose (ULD) CT group (male:female, 7:11; mean age, 57.5 ± 13.6 years). For the
controls, we retrospectively searched electronic medical records for patients with the same
inclusion criteria but who underwent follow-up CT with the routine standard dose protocol in
the same CT room during the same study period. Finally, 14 patients (male:female, 11:3; mean
age, 64.8 ± 8.5 years) were included in the control group. In the ULD group, 10 patients had
liver abscesses and 8 had renal abscesses, whereas all patients in the control group had liver
abscesses.
CT acquisition
All CT examinations in the study population included the portal venous phase (PVP), while
the precontrast or late arterial phase was optionally obtained at the discretion of the perform-
ing physician. Radiation doses were estimated and images were analyzed on the PVP. Con-
trast-enhanced CT was performed after an intravenous injection of 2.0 mL/kg (up to a
maximum 150 mL when patients weighed more than 75 kg) of iodinated contrast media (300
Table 1. Radiation doses in the phantom experiment.
DRI CTDIvol (mGy) DLP (mGy�cm) ED (mSv)
9 2.9 164.0 2.5
10 3.3 186.7 2.8
11 3.7 209.3 3.1
12 4.1 231.9 3.5
13 4.6 260.2 3.9
14 5.1 288.5 4.3
15 5.8 328.1 4.9
DRI, dose right index; CTDIvol, CT dose index volume; DLP, dose length product; ED, effective dose.
https://doi.org/10.1371/journal.pone.0246532.t001
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mgI/mL) followed by a bolus injection of 20 mL of saline chaser. Using the bolus tracking tech-
nique, CT scans in the PVP were obtained approximately 55 s after the attenuation of the
abdominal aorta increased 100 HU compared to the baseline.
Initial CT scans in the emergency room were performed with a 128-detector CT (Revolu-
tion EVO, GE Healthcare, Waukesha, WI). Parameters for the CT scan were as follows: tube
voltage, 120 kV; tube current, 100–350 mAs with tube current modulation; noise index, 22.52;
pitch, 0.984; rotation time, 0.5 s; beam collimation, 40 mm, and section thickness, 3 mm. The
protocol for the initial CT scan in the emergency room was identical between the ULD and
control groups.
Follow-up CT was performed with a 128 slice CT with double z-sampling (Brilliance iCT,
Philips Healthcare, Cleveland, OH). In this CT machine, the DRI was used to adjust radiation
exposure according to patient group. By using the DRI, the default mAs was determined based
on estimated body weight. For the control group, DRI was 15 according to the routine CT pro-
tocol in our institution. For ultralow-dose CT (the ULD group), DRI was set as 9 in the PVP to
reduce radiation dose 50–70% compared to standard-dose CT based on the previous phantom
experiment. After determining the default mAs with DRI, AEC was also applied. CT parame-
ters except DRI were the same between the ULD and control groups as follows: tube voltage,
120 kV; pitch, 0.899; rotation time, 0.5 s; beam collimation, 128 × 0.625 mm, and section thick-
ness, 3 mm. To measure the radiation dose, the CT dose index volume (CTDIvol) and dose
length product (DLP) in the PVP were recorded.
Image reconstruction
In both the ULD and control groups, initial standard-dose CT in the emergency room was
reconstructed using the 20% Adaptive Statistical Iterative Reconstruction (ASIR) algorithm
which was incorporated in the routine protocol of our institution. For follow-up low-dose CT
in the ULD group, two IR methods, iDose and iterative model reconstruction (IMR), were
applied in this study. iDose is a hybrid IR algorithm, with different levels (1 to 6 or 7 depending
on the scan protocol) of noise reduction according to the degree of noise removal. A higher
iDose level indicates a higher strength of noise removal, with an increase of approximately
11%–55% compared to the corresponding filtered back projection (FBP) reconstruction [23].
IMR is an advanced model- and knowledge-based IR algorithm [24]. Similar to iDose, image
noise is adjusted to IMR levels (1–3), and higher IMR levels indicate a larger degree of noise
reduction. Ultralow-dose CT images during the PVP in the ULD group were reconstructed
using FBP, iDose and IMR in the console. Therefore, nine imaging sets (iDose levels 1–6, and
IMR levels 1–3) were generated for IR in the ULD group. The reconstructed slice thickness
was 3 mm without overlap for all reconstruction image sets. Follow-up standard-dose CT in
the control group was reconstructed with only iDose level 3 according to the routine protocol
of our institution.
Image analysis
Quantitative analysis was performed in the ULD group to select a reconstruction phase of the
follow-up ultralow-dose CT which showed the most similar objective image noise with initial
standard-dose CT. Then, this reconstruction phase of ultralow-dose CT was used for further
qualitative image analysis. One abdominal radiologist (with 7 years of experience in abdominal
CT) performed the quantitative measurements using a picture archiving and communication
system (Centricity, GE Healthcare). Objective image noise was determined by the standard
deviation (SD) of the CT number within a region of interest (ROI) in the subcutaneous fat and
liver, respectively. In the subcutaneous fat, three circular ROIs (85.7–135.5 mm2) were drawn
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as large as possible in different levels of the abdominal wall while avoiding vessels or heteroge-
neous areas. In the liver, three circular ROIs (94.5–156.8 mm2) were also drawn as large as pos-
sible in different locations of the liver (right anterior section, right posterior section, and left
hemiliver). These ROIs were placed carefully to exclude blood vessels, bile duct, and focal
hepatic lesions. The contrast-to-noise ratio (CNR) was measured as (MDlesion—MDperilesion)/
SDfat. MDlesion was the mean lesion density (abscess), MDperilesion was the mean density of the
adjacent liver (or renal cortex), and SDfat was the SD measured in the subcutaneous fat. The
location and size of the measured ROIs were identical between the initial standard-dose CT
scan and the follow-up ultralow-dose CT scan. The mean values of the three ROIs were used
for further analysis.
For qualitative analysis, two board-certified radiologists with 7 and 13 years of experience
in abdominal CT independently reviewed the CT images. Prior to image analysis, imaging
data were anonymized to exclude patient information, thus both reviewers were blinded to the
patient group (ULD or control group). For both the ULD and control groups, the image qual-
ity of the follow-up CT scans was compared with the initial CT scans. Because follow-up CT in
the ULD group had many reconstructed phases (FBP and nine IR imaging sets), one recon-
struction phase was selected based on the aforementioned quantitative analysis. Overall image
quality, subjective image noise, artificial texture, and diagnostic confidence for the evaluation
of abscess were evaluated using a five-point Likert scale, and higher scores indicated better
image quality. For overall image quality, scores were defined as follows: 1, much poorer image
quality than initial CT; 2, slightly poorer than initial CT; 3, similar to the initial CT; 4, slightly
better than initial CT; and 5, much better than initial CT. For subjective noise and artificial tex-
ture, scores were graded as follows: 1, much more noise (artificial texture) than initial CT; 2,
slightly more than initial CT; 3, similar to initial CT; 4, slightly less than initial CT, and 5,
much less than initial CT. Diagnostic confidence for the evaluation of abscess was scored using
the following criteria: 1, non-diagnostic; 2, considerably degrading diagnostic confidence; 3,
slightly degrading diagnostic confidence; 4, minimally degrading diagnostic confidence; and 5,
not affecting diagnostic confidence.
Statistical analysis
Baseline patient demographics and radiation dose were compared between the ULD group
and control group using independent t-tests for continuous variables and Pearson’s chi-
squared test or Fisher’s exact test for categorical variables. In the ULD group, SDs measured in
the subcutaneous fat and liver, and CNRs were compared between the initial CT and each
reconstruction phase of the follow-up CT using paired t-tests. To compare qualitative parame-
ters between the ULD and control groups, and between patients with body mass index (BMI)
< 25 kg/m2 and patients with� 25 kg/m2, the Mann-Whitney U test was used. Interobserver
agreement for qualitative analysis was evaluated between the two reviewers by percent agree-
ment and prevalence-adjusted and bias-adjusted kappa (PABAK) [25]. PABAK statistics were
interpreted as follows: 0.01–0.20, slight agreement; 0.21–0.40, fair agreement; 0.41–0.60, mod-
erate agreement; 0.61–0.80, substantial agreement; and 0.81–0.99, almost perfect agreement
[26]. Statistical analyses were conducted using SPSS Statistics version 25.0 (IBM Corp., New
York, NY). P values smaller than 0.05 were considered statistically significant.
Results
Patient demographics and radiation dose measurements
The ULD group consisted of 18 patients, and the control group 14 patients. Patient demo-
graphics and CT radiation doses are summarized in Table 2. BMI was not significantly
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different between the ULD and control groups (23.4 ± 3.2 vs. 22.9 ± 3.4, P = 0.667). The size of
the abscess measured on follow-up CT was not significantly different between the ULD and
control groups (1.7 ± 0.3 cm vs. 1.8 ± 1.5 cm, P = 0.807). Intervals between the initial and fol-
low-up CT were comparable between the ULD and control groups (36.9 ± 8.1 vs. 33.8 ± 10.9
days, P = 0.338). Regarding radiation dose, the CTDIvol and DLP of the initial CT were not
significantly different between the ULD and control groups (9.2 ± 3.5 vs. 9.7 ± 2.8 mGy,
P = 0.536 for CTDIvol; and 521.9 ± 229.5 vs. 561.6 ± 182.6 mGy�cm, P = 0.398 for DLP). The
CTDIvol and DLP of the follow-up CT were significantly lower in the ULD group compared
to the control group (2.4 ± 0.6 vs. 8.7 ± 1.8 mGy, P< 0.001 for CTDIvol; and 151.5 ± 42.5 vs.
555.8 ± 142.8 mGy�cm, P< 0.001 for DLP). Compared to the initial standard-dose CT in the
ULD group, ultralow-dose CT showed a mean dose reduction of 71.8% (median, 72.8%; range,
57.0–80.3%) for CTDIvol and 68.4% (median, 71.0%; range, 49.2–76.8%) for DLP,
respectively.
Quantitative analysis
The objective image noises of initial and follow-up CT scans in the ULD group are summa-
rized in Table 3. In the subcutaneous fat, the mean SD of the initial CT was 11.6 ± 1.1 HU. The
SDs measured on iDose 4 (11.5 ± 1.9, P = 0.932) and iDose 5 (10.7 ± 1.7, P = 0.076) of follow-
up ultralow-dose CT were comparable to initial CT. In the liver, the mean SD of the initial CT
was 14.7 ± 2.9 HU. On follow-up CT, SDs measured on iDose 5 (16.2 ± 2.8, P = 0.124) and
iDose 6 (13.9 ± 2.2, P = 0.329) were not significantly different from those measured on initial
Table 2. Patient demographics and radiation dose.
ULD group (n = 18) Control group (n = 14) P value
Age (Years) 57.5 ± 13.6 64.8 ± 8.5 0.152
Sex 0.059
Male 7 (38.9%) 11 (78.6%)
Female 11 (61.1%) 3 (21.4%)
BMI (kg/m2) 23.4 ± 3.2 22.9 ± 3.4 0.667
<18.5 0 2 (14.3%)
18.5–24.9 14 (77.8%) 7 (50%)
�25 4 (22.2%) 5 (35.7%)
Diagnosis 0.034
Liver abscess 10 (55.6%) 14 (100%)
Kidney abscess 8 (44.4%) 0 (0%)
Size of abscess (cm)
On initial CT 3.1 ± 2.0 2.6 ± 1.5 0.457
On follow-up CT 1.7 ± 0.3 1.8 ± 1.5 0.807
CT interval (days)� 36.9 ± 8.1 33.8 ± 10.9 0.338
Radiation dose
CTDIvol of initial CT (mGy) 9.2 ± 3.5 9.7 ± 2.8 0.536
CTDIvol of follow-up CT (mGy) 2.4 ± 0.6 8.7 ± 1.8 <0.001
DLP of initial CT (mGy�cm) 521.9 ± 229.5 561.6 ± 182.6 0.398
DLP of follow-up CT (mGy�cm) 151.5 ± 42.5 555.8 ± 142.8 <0.001
Data are mean ± standard deviation.
�Time interval between initial and follow-up CT scans.
ULD, ultralow-dose; BMI, body mass index; CTDIvol, CT dose index volume; DLP, dose length product.
https://doi.org/10.1371/journal.pone.0246532.t002
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CT. Thus, iDose 5 was selected for further qualitative image analysis because it showed similar
SDs in both the subcutaneous fat and liver. Regarding CNR, initial standard-dose CT and fol-
low-up CT scans with iDose showed similar CNR values in the ULD group, and the CNR was
even higher with IMR, probably due to decreases in image noise.
Qualitative analysis
Overall image quality (2.3 ± 0.5 vs. 3.1 ± 0.5, P< 0.001 for reader 1, and 2.3 ± 0.7 vs. 3.1 ± 0.7,
P = 0.005) and subjective image noise (2.1 ± 0.8 vs. 2.9 ± 0.6, P = 0.004 for reader 1, and
2.2 ± 0.6 vs. 3.2 ± 0.7, P = 0.001 for reader 2) of follow-up CT in the ULD group were signifi-
cantly worse than the control group (Table 4). Artificial texture of follow-up CT was not signif-
icantly different between the ULD and control group (P = 750 for reader 1, and P = 0.694 for
reader 2). Despite slightly worse image quality and noise in the ULD group, the diagnostic
confidence of follow-up ultralow-dose CT for the evaluation of abscess (4.9 ± 0.3 vs. 5.0 ± 0.0,
P = 0.808 for reader 1, and 4.7 ± 0.6 vs. 5.0 ± 0.0, P = 0.301 for reader 2) was comparable to
standard-dose CT (Figs 1 and 2). For abscess size, there was no significant difference in the
diagnostic confidence in the control group (5.0 ± 0.0 vs. 5.0 ± 0.0, P> 0.999 for both readers).
Table 4. Qualitative analysis.
ULD group (n = 18) Control group (n = 14) P value
Overall image quality
Reader 1 2.3 ± 0.5 3.1 ± 0.5 <0.001
Reader 2 2.3 ± 0.7 3.1 ± 0.7 0.005
Noise
Reader 1 2.1 ± 0.8 2.9 ± 0.6 0.004
Reader 2 2.2 ± 0.6 3.2 ± 0.7 0.001
Artificial texture
Reader 1 3.0 ± 0.0 3.1 ± 0.3 0.750
Reader 2 3.2 ± 0.5 3.1 ± 0.5 0.694
Diagnostic confidence
Reader 1 4.9 ± 0.3 5.0 ± 0.0 0.808
Reader 2 4.7 ± 0.6 5.0 ± 0.0 0.301
Data are mean ± standard deviation.
ULD, ultralow-dose.
https://doi.org/10.1371/journal.pone.0246532.t004
Table 3. Objective image noise (SD) of initial and follow-up CT scans in the ULD group.
Initial CT Follow-up ultralow-dose CT
Standard FBP iDose 1 iDose 2 iDose 3 iDose 4 iDose 5 iDose 6 IMR 1 IMR 2 IMR 3
SQ fat 11.6 ± 1.1 22.0 ± 4.7 14.4 ± 2.4 13.4 ± 2.4 12.8 ± 2.2 11.5 ± 1.9 10.7 ± 1.7 9.7 ± 1.7 7.8 ± 1.1 6.8 ± 1.0 5.7 ± 0.9
P-value < 0.001 < 0.001 0.010 0.035 0.932 0.076 0.001 < 0.001 < 0.001 < 0.001
Liver 14.7 ± 2.9 39.9 ± 10.1 23.0 ± 3.4 21.5 ± 3.1 20.3 ± 3.2 18.3 ± 2.7 16.2 ± 2.8 13.9 ± 2.2 9.8 ± 1.4 8.0 ± 1.2 6.1 ± 1.1
P-value < 0.001 < 0.001 < 0.001 < 0.001 0.001 0.124 0.329 < 0.001 < 0.001 < 0.001
CNR 7.4 ± 2.8 5.1 ± 3.7 7.3 ± 3.8 8.0 ± 4.3 8.4 ± 4.3 8.9 ± 5.0 9.5 ± 4.9 10.2 ± 4.6 14.1 ± 8.6 16.0 ± 11.1 19.1 ± 12.1
P-value 0.028 0.802 0.730 0.300 0.397 0.090 0.060 0.006 0.002 0.001
Data are mean ± standard deviation.
P-values are for differences between standard-dose initial CT and each reconstruction of follow-up ultralow-dose CT.
SD, standard deviation; ULD, ultralow-dose; SQ, subcutaneous; CNR, contrast-to-noise ratio; FBP, filtered back projection; IMR, iterative model reconstruction.
https://doi.org/10.1371/journal.pone.0246532.t003
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Also in the ULD group, there was no significant difference in the diagnostic confidence
(4.9 ± 0.3 vs. 5.0 ± 0.0, P = 0.791 for reader 1; and 4.6 ± 0.7 vs. 4.9 ± 0.4, P = 0.659 for reader 2)
according to abscess size (< 2 cm vs.� 2 cm). All of these qualitative parameters did not sig-
nificantly differ between patients with BMI < 25 kg/m2 and those with BMI� 25 kg/m2 in
both the ULD and control groups (S1 Table).
Fig 1. Contrast-enhanced CT images of a 46-year-old man with liver abscesses. Body mass index was 30.7 kg/m2. (A) Initial standard-dose CT shows several low
attenuation lesions in the right hemiliver (arrows), suggestive of liver abscesses. (B) Follow-up ultralow-dose CT shows the liver abscesses decrease in size (arrows). The
CT dose index volume of initial CT and follow-up CT was 15.4 mGy and 3.7 mGy, respectively. Image quality and noise were worse on follow-up CT, but diagnostic
confidence was relatively preserved. The scores for image quality, noise, and diagnostic confidence were 2, 1, and 5 for reader 1, and 1, 1, and 4 for reader 2.
https://doi.org/10.1371/journal.pone.0246532.g001
Fig 2. Contrast-enhanced CT images of a 61-year-old woman with liver abscesses. Body mass index was 20.4 kg/m2. (A) Initial standard-dose CT shows clustered
peripheral enhancing lesions in the right posterior liver (arrow), suggestive of liver abscesses. (B) Follow-up ultralow-dose CT shows liver abscess nearly resolved
(arrow). The CT dose index volume of initial CT and follow-up CT was 5.7 mGy and 1.8 mGy, respectively. Image quality and noise were comparable between initial CT
and follow-up CT, and the diagnostic confidence of follow-up ultralow-dose CT was excellent. The scores for image quality, noise, and diagnostic confidence were 3, 3,
and 5 for both readers.
https://doi.org/10.1371/journal.pone.0246532.g002
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Interobserver agreement for qualitative analysis was moderate for overall image quality
(PABAK, 0.531) and noise (0.453), and substantial to almost perfect for artificial texture
(0.648) and diagnostic confidence on abscess evaluation (0.883, Table 5).
Discussion
This study investigated the feasibility of using ultra-low dose CT to follow intra-abdominal
abscesses in adult patients. Using our protocol, the radiation dose of ultralow-dose CT (mean
CTDIvol of 2.4 mSv) was approximately 70% lower than standard-dose CT. The subjective
image quality and noise of follow-up ultralow-dose CT with IR were slightly worse than stan-
dard-dose CT in the control group. However, ultralow-dose CT and standard-dose CT did not
differ in the diagnostic confidence to evaluate treatment response and to determine manage-
ment plans. Also, when patients were classified according to BMI, all these qualitative parame-
ters (overall image quality, noise, artificial texture, and diagnostic confidence) did not differ
between patients with BMI< 25 kg/m2 and those with BMI� 25 kg/m2 in both the ULD and
control groups.
In patients with suspected intra-abdominal abscess such as liver or renal abscess, contrast-
enhanced CT is usually required to establish a diagnosis, and to evaluate the size, anatomy,
and characteristics of the abscess [27, 28]. After appropriate management, patients usually
undergo follow-up CT when clinical symptoms persist or when treatment response needs to
be evaluated. A recent study of patients with inflammatory bowel disease reported the mean
total effective dose as 51.6 ± 44.7 mSv during an abscess episode, although this included fluoro-
scopic studies for drainage procedures as well as intervening CT scans [13]. In contrast to ini-
tial CT performed to establish a diagnosis, the not perfect image quality of follow-up CT for
intra-abdominal abscess can be tolerated, because the primary disease has already been diag-
nosed and located on initial CT. One study showed that ultralow-dose CT that reduced radia-
tion dose by 72% compared to conventional CT could detect intra-abdominal abscess in all
patients with Crohn’s disease (3/3) [29]. Our study which included a larger number of patients
with hepatic and renal abscesses also confirmed this hypothesis, although further studies with
more patients with different types of abscesses or other ethnicities are warranted.
Among the two IR algorithms available in this study, iDose and IMR, iDose level 5 was
selected for the ultralow-dose CT protocol, based on measurements of objective image noise.
These two IR algorithms use different mechanisms for noise reduction: iDose is an IR algo-
rithm that works in the combined projection and image domains, whereas IMR is a model-
based IR algorithm [30–32]. The most essential difference between iDose and IMR is that IMR
decreases both quantum noise and non-random noise intrinsic to the geometry and optics of
the imaging system [33, 34]. According to previous studies, IMR can provide more dramatic
dose reduction, but obtains more blotchy images and poor demarcation of anatomic structures
which deteriorates its diagnostic confidence [34, 35]. Therefore, several previous studies have
recommended the use of an intermediate level of iDose (3–4) to preserve the image quality of
Table 5. Interobserver agreement for qualitative analysis.
% agreement PABAK 95% CI
Overall image quality 59.4 0.531 0.393, 0.670
Noise 50.0 0.453 0.315, 0.592
Artificial texture 71.9 0.648 0.510, 0.787
Diagnostic confidence 90.6 0.883 0.744, 1.021
PABAK, Prevalence-Adjusted and Bias-Adjusted Kappa; CI, confidence interval.
https://doi.org/10.1371/journal.pone.0246532.t005
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abdominopelvic CT [34, 36]. Based on our study results, we suggest that a relatively higher IR
level (iDose level 5) could be used with ultralow-dose CT to follow liver or renal abscess, while
allowing more dramatic dose reduction.
This study has several limitations. First, the small number of patients included in our analy-
sis may limit the power of this study. Also, the BMI of our study population was quite low
(mean ± SD, 23.4 ± 3.2), probably because it was made up of Asian patients. Inclusion of more
obese patients could possibly decrease the diagnostic ability of ultralow-dose CT. Second, the
different exam dates of the initial and follow-up CT scans may limit the side-by-side compari-
son of qualitative image parameters and abscess. However, the main focus of this study was to
evaluate the feasibility of using ultralow-dose CT to follow liver and renal abscess. Further-
more, repeated acquisition of CT scans at the same time is unethical due to increased radiation
exposure. Third, we compared different patient groups with different pathologies between the
ULD and control groups. ULD group consisted of both liver or kidney abscesses, whereas the
control group included patients with liver abscess only. Therefore, we were not able to com-
pare other associated findings such as thrombophlebitis in the portal vein between the study
and control groups. Finally, specific IR algorithms from a CT scanner from only one vendor
were used. Also, only a specific IR method (iDose 3) was available for standard-dose CT com-
pared to the 10 reconstructed datasets of ultralow-dose CT, because standard-dose CT was
performed according to routine CT protocol. Hence, further studies that incorporate various
IR techniques from other vendors are required to generalize our study results.
In conclusion, ultralow-dose CT combined with the IR technique can achieve approxi-
mately 70% dose reduction relative to conventional CT and can be used in the follow-up of
liver and renal abscess with comparable diagnostic confidence.
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